MIRA INFORM REPORT

 

 

Report No. :

347984

Report Date :

04.11.2015

 

IDENTIFICATION DETAILS

 

Name :

SARACA LABORATORIES LIMITED (w.e.f. 28.11.1994)

 

 

Formerly Known As :

SARACA LABORATORIES PRIVATE LIMITED (w.e.f. 02.05.1989)

 

V C R DRUGS PRIVATE LIMITED

 

 

Registered Office :

Plot No.320, 1st Floor, Swamy Ayyappa Co-Operative, Housing Society Limited, Maadhapur, Hyderabad-500081, Telangana

Tel. No.:

91-40-23112689

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

11.01.1988

 

 

Com. Reg. No.:

008172

 

 

Capital Investment / Paid-up Capital :

Rs. 80.000 Million

 

 

CIN No.:

[Company Identification No.]

U85195TG1988PLC008172

 

 

IEC No.:

0991007859

 

 

TIN No.:

28940115205

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AACCS8240H

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs.

 

 

No. of Employees :

250 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1771800

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. It was incorporated during the year 1988, engaged in manufacturing and exporting of bulk drugs.

 

The company’s overall financial position seems to be good with decent profit margins along with sound capital structure backed by its healthy net worth base, strong debt protection metrics and favourable liquidity position during the year 2015.

 

Rating further takes into consideration company’s long track record of business operations and established market position in pharmaceutical industry.

 

However, rating strength is partially offset by risk associated to product substitution, exposure to intense competition and risks related to volatility in raw material prices.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Bank Facilities=BBB+

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

18.09.2014

 

 

Rating Agency Name

CRISIL

Rating

Short term Bank Facilities=A2

Rating Explanation

Strong degree of safety and low credit risk

Date

18.09.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Srinivas Reddy

Designation :

Accounts Manager

Contact No.:

91-40-23112689

Date :

31.10.2015

 

 

LOCATIONS

 

Registered Office :

Plot No.320, 1st Floor, Swamy Ayyappa Co-Operative, Housing Society Limited, Maadhapur, Hyderabad-500081, Telangana, India

Tel. No.:

91-40-23112689/ 690

Fax No.:

91-40-23112691

E-Mail :

accounts@saraca.com

info@saraca.com

Website :

http://www.saraca.com

 

 

Factory 1:

Paidi Bemavaram, Srikakulam District Hyderabad, Telangana, India

 

 

Factory  2:

Survey No. 10, Gaddapotharam Village, Jinnaram Mandal, Medak District, Andhra Pradesh, India

Tel. No.:

91-7702301723/ 27

Fax No. :

91-8458-277189

 

 

DIRECTORS

 

AS ON 29.09.2014

 

Name :

Mr. Venkata Sunil Lingareddy

Designation :

Director

Address :

Plot No.435 A, Road No.20, Jubilee Hills, Hyderabad-500034, Andhra Pradesh, India

Date of Birth/Age :

17.07.1974

Qualification :

Graduate/PG

Date of Appointment :

06.04.2000

DIN No.:

00268393

 

 

Name :

Mr. Subramanyam Reddy Puthana

Designation :

Managing Director

Address :

8-2-469/C C-2, Road No.5, Banjara Hills, Hyderabad-500034, Andhra Pradesh, India

Date of Birth/Age :

01.05.1945

Qualification :

Graduate/PG

Date of Appointment :

16.12.1994

DIN No.:

00268514

 

 

Name :

Mr. Venkata Subba Reddy Lingareddy

Designation :

Whole-time director

Address :

8-2-293/82/A/435/A, Road No.20, Jubilee Hills, Hyderabad-500033, Andhra Pradesh, India

Date of Birth/Age :

01.07.1941

Qualification :

Graduate/PG

Date of Appointment :

03.03.1992

DIN No.:

00268559

 

 

Name :

Mr. Sree Phani Kumar Reddy Mallidi

Designation :

Director

Address :

No 3, S L N Lumbini Springs, Kothaguda, Shaikpet, Jubilee Hills, Hyderabad- 500033, Telangana, India

Date of Birth/Age :

26.10.1971

Qualification :

Graduate/PG

Date of Appointment :

09.05.1997

DIN No.:

00307899

 

 

Name :

Mr. Maha Vishnu Mundla

Designation :

Director

Address :

Plot No.15A, Road No.2, Jubilee Hills, Hyderabad-500033, Andhra Pradesh, India

Date of Birth/Age :

15.02.1987

Qualification :

Graduate/PG

Date of Appointment :

17.02.2006

PAN No.:

AMWPM8438Q

DIN No.:

02470664

 

 

KEY EXECUTIVES

 

Name :

Mr. Srinivas Reddy

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

NOTE: SHAREHOLDING DETAILS FILE ATTACHED

 

 

AS ON 29.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         Iran

Bangladesh

USA

Canada

China

 

 

Imports :

 

Products :

Raw Material

Countries :

·         China

Korea

 

 

Terms :

 

Selling :

Cheque and Credit

 

 

Purchasing :

Cheque and Credit

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

End Users and OEMs

 

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

250 (Approximately)

 

 

Bankers :

Bank Name:

State Bank of Hyderabad

Branch:

Punjagutta Branch, Rose Made, H.No. 6-3-542/2, Punjagutta, Hyderabad - 500082, Andhra pradesh, India

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Cash Credit=Rs. 730.000 Million

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

0.000

20.334

Loans taken for fixed assets

1.366

0.525

 

 

 

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

202.674

336.112

 

 

 

Total

204.040

356.971

 

Banking Relations :

--

 

 

Auditors :

 

Name :

P Murali and Company

Chartered Accountants

Address :

No. 6-3-655/2/3, Somajiguda, Hyderabad, Andhra Pradesh, India

Income-tax PAN of auditor or auditor's firm :

AADFP2033K

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Related Parties :

·         Virchow Laboratores Limited, India (U24232TG1982PLC003368)

Andhra Organics Limited, India (U24116TG1991PLC012314)

Emmennar Pharma Containers Private Limited, India (U21014TG2001PTC037859)

Virchow Chemicals Private Limited, India (U65910TG1988PTC008596)

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8,000,000

Equity Shares

Rs. 10/- each

Rs. 80.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8,000,000

Equity Shares

Rs. 10/- each

Rs. 80.000 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

80.000

80.000

80.000

(b) Reserves & Surplus

540.158

385.712

325.828

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

620.158

465.712

405.828

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

47.724

42.025

55.084

(b) Deferred tax liabilities (Net)

54.618

49.179

44.229

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

2.210

2.718

3.320

Total Non-current Liabilities (3)

104.552

93.922

102.633

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

202.674

336.112

275.640

(b) Trade payables

408.335

288.844

218.916

(c) Other current liabilities

0.442

20.334

21.667

(d) Short-term provisions

162.525

67.073

70.255

Total Current Liabilities (4)

773.976

712.363

586.478

 

 

 

 

TOTAL

1498.686

1271.997

1094.939

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

505.093

448.953

416.131

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.192

0.192

0.192

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

28.384

46.776

10.838

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

533.669

495.921

427.161

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

227.144

191.845

176.442

(c) Trade receivables

620.743

524.368

412.022

(d) Cash and cash equivalents

15.617

10.957

26.537

(e) Short-term loans and advances

0.873

0.366

0.368

(f) Other current assets

100.640

48.540

52.409

Total Current Assets

965.017

776.076

667.778

 

 

 

 

TOTAL

1498.686

1271.997

1094.939

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Opertaions

2604.128

1895.073

1504.183

 

 

Other Income

11.847

11.621

29.655

 

 

TOTAL                                     (A)

2615.975

1906.694

1533.838

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1796.473

1359.387

1094.762

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(17.413)

(7.113)

(21.064)

 

 

Employees benefits expense

71.041

56.414

46.147

 

 

Other expenses

468.770

346.825

271.492

 

 

TOTAL                                     (B)

2318.871

1755.513

1391.337

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

297.104

151.181

142.501

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

32.973

35.379

28.417

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

264.131

115.802

114.084

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

29.210

26.185

23.778

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

234.921

89.617

90.306

 

 

 

 

 

Less

TAX                                                                  (H)

80.475

29.734

0.000

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

154.446

59.883

90.306

 

 

 

 

 

 

Earnings Per Share (Rs.)

19.31

7.49

11.29

 

 

PARTICULARS

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

2680.000

 

 

 

 

 

Expected Sales (2015-2016): Rs. 2750.000 Million

 

The above information has been parted by Mr. Srinivas Reddy (Accounts Manager)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

0.442

20.334

21.667

 

 

 

 

Cash Generated from Operations

NA

NA

NA

 

 

 

 

Net Cash Flow from used in Operations

NA

NA

NA

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

5.93

3.16

6.00

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

11.41

7.98

9.47

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

15.68

7.05

8.25

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.38

0.19

0.22

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.40

0.86

0.87

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.25

1.09

1.14

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

80.000

80.000

80.000

Reserves & Surplus

325.828

385.712

540.158

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

405.828

465.712

620.158

 

 

 

 

Long-term borrowings

55.084

42.025

47.724

Short term borrowings

275.640

336.112

202.674

CURRENT MATURITIES OF LONG-TERM DEBTS

21.667

20.334

0.442

Total borrowings

352.391

398.471

250.840

Debt/Equity ratio

0.868

0.856

0.404

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1504.183

1895.073

2604.128

 

 

25.987

37.416

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1504.183

1895.073

2604.128

Profit

90.306

59.883

154.446

 

6.00%

3.16%

5.93%

 

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

90118968

28/03/2000

400,000.00

STATE BVANK OF HYDERABAD

PUNJAGUTTA BRANCH, HYDERABAD, ANDHRA PRADESH, INDIA

-

2

90118966

16/03/2000

5,000,000.00

STATE BANK OF HYDERABAD

PUNJAGUTTA BRANCH, HYDERABAD, ANDHRA PRADESH, INDIA

-

3

90114045

19/04/1996

4,700,000.00

STATE BANK OF HYDERABAD

PUNJAGUTTA BRANCH, HYDERABAD, ANDHRA PRADESH, INDIA

-

4

90118489

20/04/2015 *

710,000,000.00

STATE BANK OF HYDERABAD

H.NO: 6-3-542/2, HYDERABAD- 500082, TELANGANA, INDIA

C56426588

5

90119402

10/06/1991

1,000,000.00

ANDHRA BANK

POMAJIGUDA, HYDERABAD, ANDHRA PRADESH, INDIA

-

6

90118356

10/01/1991

3,970,000.00

A P S F C. HYDERABAD

CHISAG ALI LANE, HYDERABAD, ANDHRA PRADESH, INDIA

-

 

* Date of charge modification

 

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Loans and advances from directors

4.100

6.500

Loans and advances from others

42.700

35.000

Other loans and advances, others

(0.442)

(20.334)

 

 

 

Total

46.358

21.166

 

 

CHANGE OF ADDRESS:

 

The Registered Office of the company has been shifted from 8-2-348/2, COC Building, Road No. 3, Beside Administrative Staff College, Banjara Hills, Hyderabad-500034, Andhra Pradesh, India to the present address w.e.f 01.04.2011


PROJECT IMPLEMENTATION:

 

In presenting the 2013-14 performances. The Turnover of the year has consolidated at Rs.2604.128 Million With a growth of 37.42% and the Other Income is Rs. 1,1.847 Million. The profit during the year is Rs. 23,4.921 Million against Rs.8,9.617 Million/- last year.

 

During the year Additional Facility for NMSM is established at Pydibhimavaram Unit, to become a full fledged unit for in Ranitidine Manufacturer. Presently we are the largest manufacturer of RANITIDINE HCL in the world.

 

They are pleased to indicate that our unit has obtained USFDA, Iran Government approved and Austrian TGA Qualification etc. and exporting to over 24 Countries.

 

The unit has registration of Certificate of Suitability, which will help in obtaining orders directly from Europe.

 

During the year 2006-07 our product is approved by M/s.Glaxco, the originate of Ranitidine. Now we the only supplier to M/S. Glaxo, India.

With this we are covering 85% of Indian Market of Ranitidne HCL. This is possible due to our efficiency and Volume.

 

The company for full fledged R and D and Pilot Plant for taking up New Products and Process development of existing products. We have successfully developed Gaba Pentin HCL to TEVA ASSIA, ISRAEL and manufacturing intermediates for Promypexol and Donepezil to APOTEX, CANADA.

 

 

FIXED ASSETS:

 

Tangible Assets

 

·         Land

Buildings

Plant and Equipment

Furniture and Fixtures

Vehicles

Office Equipment

Computer Equipments

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 65.45

UK Pound

1

  Rs. 100.96

Euro

1

Rs. 72.10

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

HNA

 

 

Report Prepared by :

IND

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.